Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
Does biological age matter more than chronological age in NSCLC? New AI-derived facial age data suggest added prognostic value
A retrospective cohort study published in JAMA Network Open has evaluated whether non-invasive measures of…
From concept to clinic: mRNA vaccines advance in oncology
A recent article published in JAMA explores the emerging role of mRNA vaccines as a…
Genetic discrimination ban paves the way for expansion of life-saving DNA screening
A national legislative ban on life insurers discriminating against applicants based on genetic testing would…
EAU 2026: Scan that makes prostate cancer cells glow could cut need for biopsies
- Do prostate cancer drugs interact with certain anticoagulants to increase bleeding and clotting risks?
- ASCO GU 2026: Cancer’s clues in the bloodstream reveal the role androgen receptor alterations play in metastatic prostate cancer
- ASCO GU 2026: Hormone therapy may not benefit most men receiving radiotherapy after prostate surgery
S4 E1: Hot Flushes, Aspirin and AI
The Oncology Journal Club Podcast hosted by Professor Craig Underhill, Dr Kate Clarke and Professor Chris Jackson | Proudly Produced…
ASCO GU 2026: Enfortumab vedotin pembrolizumab combo may reduce risk of recurrence for some MIBC cases
- ASCO GU 2026: Cancer’s clues in the bloodstream reveal the role androgen receptor alterations play in metastatic prostate cancer
- ASCO GU 2026: Hormone therapy may not benefit most men receiving radiotherapy after prostate surgery
- Study identifies long-term health risks among testicular cancer survivors treated with contemporary chemotherapy regimens
How cancer misinformation exploits the way we think
Andy Levy, Edge Hill University When TV personality Danielle Lloyd was diagnosed with melanoma earlier this year, she faced not…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.